Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Six-month treatment with ciprofloxacin improves response rate in ulcerative colitis

Dec. 4, 1998

Agents for ulcers synthesized and evaluated at Shiseido

Dec. 3, 1998

AxyS initiates phase I studies of APC-2059 for treatment of acute inflammatory bowel disease

Dec. 3, 1998

Lead SelCID compound poised to enter phase II clinical trials for Crohn's disease

Dec. 2, 1998

Health Canada approves lamivudine for treatment of chronic HBV

Dec. 2, 1998

AMBI seeks partners to develop oral nisin for H. pylori eradication

Dec. 2, 1998

Multiple clinical studies support efficacy and safety of HSR-237 in patients with IBS

Nov. 30, 1998

Ferring patents dual T-cell proliferation and protein farnesyltransferase inhibitors

Nov. 27, 1998

Potent and highly selective CCK-A antagonist designed by Tobishi

Nov. 26, 1998

New compounds for immunoinflammatory and neoplastic diseases in the pipeline at Ferring

Nov. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...